Document is current
Any future updates will be listed below
-
Authors
Kunkemoeller, Britta https://orcid.org/0000-0003-0709-1577
Prendeville, Hannah
McIntyre, Claire
Temesgen, Ayantu
Loftus, Rόisín M.
Yao, Conghui
Dyck, Lydia
Sinclair, Linda V. https://orcid.org/0000-0003-1248-7189
Rollings, Christina
Douglas, Aaron https://orcid.org/0000-0002-8812-9575
Pernes, Gerard
Mitchelson, Kathleen A. J.
Harmon, Cathal
Raverdeau, Mathilde https://orcid.org/0000-0002-6088-6902
Ward, Ross https://orcid.org/0000-0001-5242-4022
Kane, Harry
Kline, Jaclyn
O’Brien, Katie L.
Brennan, Martin
Smith, Frances https://orcid.org/0000-0001-6069-1390
Stevens, Brenneth
Roche, Helen M.
Lavelle, Ed C.
Finlay, David K. https://orcid.org/0000-0003-2716-6679
Cantrell, Doreen A.
Chouchani, Edward T. https://orcid.org/0000-0002-9776-8790
Kaech, Susan https://orcid.org/0000-0003-1674-1420
Mills, Evanna L. https://orcid.org/0000-0003-0447-8995
Haigis, Marcia https://orcid.org/0000-0003-2530-2681
Lynch, Lydia https://orcid.org/0000-0002-4273-4681
-
Funding
Funding for this research was provided by:
Science Foundation Ireland
Ludwig Institute for Cancer Research
Irish Research Council for Science, Engineering and Technology
Irish Research Council
- License Information
-
More Information
Article History
Received: 25 October 2024
Accepted: 6 June 2025
First Online: 25 July 2025
Competing interests
: L.L. is a member of the scientific advisory board for MiNK Therapeutics, a consultant for Bayer and a member of the Scientific Advisory Board of Faeth Therapeutics and Deciduous Therapeutics. The interests of L.L. were reviewed and managed by the Brigham and Women’s Hospital in accordance with their conflict-of-interest policies. M.H. is a member of the Scientific Advisory Board of the MD Anderson Allison Institute. The other authors declare no competing interests.
